Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma

Barbara Pro; Steven M. Horwitz; H. Miles Prince; Francine M. Foss; Lubomir Sokol; Matthew Greenwood; Dolores Caballero; Franck Morschhauser; Martin Wilhelm; Swaminathan Padmanabhan Iyer; Andrei R. Shustov; Julie Wolfson; Barbara E. Balser; Bertrand Coiffier

doi:10.1002/hon.2320

Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma

Barbara Pro, Steven M. Horwitz, H. Miles Prince, Francine M. Foss, Lubomir Sokol, Matthew Greenwood, Dolores Caballero, Franck Morschhauser, Martin Wilhelm, Swaminathan Padmanabhan Iyer, Andrei R. Shustov, Julie Wolfson, Barbara E. Balser, Bertrand Coiffier

Lymphoma-Myeloma

Research output: Contribution to journal › Letter › peer-review

37 Scopus citations

Original language	English (US)
Pages (from-to)	914-917
Number of pages	4
Journal	Hematological Oncology
Volume	35
Issue number	4
DOIs	https://doi.org/10.1002/hon.2320
State	Published - Dec 2017

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1002/hon.2320

Cite this

Pro, B., Horwitz, S. M., Prince, H. M., Foss, F. M., Sokol, L., Greenwood, M., Caballero, D., Morschhauser, F., Wilhelm, M., Iyer, S. P., Shustov, A. R., Wolfson, J., Balser, B. E., & Coiffier, B. (2017). Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma. Hematological Oncology, 35(4), 914-917. https://doi.org/10.1002/hon.2320

Pro, B, Horwitz, SM, Prince, HM, Foss, FM, Sokol, L, Greenwood, M, Caballero, D, Morschhauser, F, Wilhelm, M, Iyer, SP, Shustov, AR, Wolfson, J, Balser, BE & Coiffier, B 2017, 'Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma', Hematological Oncology, vol. 35, no. 4, pp. 914-917. https://doi.org/10.1002/hon.2320

@article{1cf0b29baeea42949b5cece203691251,

title = "Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma",

author = "Barbara Pro and Horwitz, {Steven M.} and Prince, {H. Miles} and Foss, {Francine M.} and Lubomir Sokol and Matthew Greenwood and Dolores Caballero and Franck Morschhauser and Martin Wilhelm and Iyer, {Swaminathan Padmanabhan} and Shustov, {Andrei R.} and Julie Wolfson and Balser, {Barbara E.} and Bertrand Coiffier",

note = "Funding Information: The authors take full responsibility for the content of this manuscript but thank William Ho, PhD (MediTech Media), for providing medical editorial assistance. Financial support for medical editorial assistance was provided by Celgene Corporation.",

year = "2017",

month = dec,

doi = "10.1002/hon.2320",

language = "English (US)",

volume = "35",

pages = "914--917",

journal = "Hematological Oncology",

issn = "0278-0232",

publisher = "John Wiley and Sons Ltd",

number = "4",

}

TY - JOUR

T1 - Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma

AU - Pro, Barbara

AU - Horwitz, Steven M.

AU - Prince, H. Miles

AU - Foss, Francine M.

AU - Sokol, Lubomir

AU - Greenwood, Matthew

AU - Caballero, Dolores

AU - Morschhauser, Franck

AU - Wilhelm, Martin

AU - Iyer, Swaminathan Padmanabhan

AU - Shustov, Andrei R.

AU - Wolfson, Julie

AU - Balser, Barbara E.

AU - Coiffier, Bertrand

N1 - Funding Information: The authors take full responsibility for the content of this manuscript but thank William Ho, PhD (MediTech Media), for providing medical editorial assistance. Financial support for medical editorial assistance was provided by Celgene Corporation.

PY - 2017/12

Y1 - 2017/12

UR - http://www.scopus.com/inward/record.url?scp=84994087158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994087158&partnerID=8YFLogxK

U2 - 10.1002/hon.2320

DO - 10.1002/hon.2320

M3 - Letter

C2 - 27402335

AN - SCOPUS:84994087158

SN - 0278-0232

VL - 35

SP - 914

EP - 917

JO - Hematological Oncology

JF - Hematological Oncology

IS - 4

ER -

Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this